tiprankstipranks
Advertisement
Advertisement

CASI Stock Latest News

Eight new option listings and two option delistings on February 27th
The FlyEight new option listings and two option delistings on February 27th
4M ago
ASM
CASI
CASI Pharmaceuticals to Be Delisted From Nasdaq, Shares Expected to Move to OTC Market
PremiumCompany Announcements
CASI Pharmaceuticals to Be Delisted From Nasdaq, Shares Expected to Move to OTC Market
4M ago
6K
CASI
Casi Pharmaceuticals receives delisting decision from Nasdaq
PremiumThe Fly
Casi Pharmaceuticals receives delisting decision from Nasdaq
4M ago
CASI
Casi Pharmaceuticals receives delisting decision from Nasdaq
PremiumThe Fly
Casi Pharmaceuticals receives delisting decision from Nasdaq
4M ago
CASI
CASI Pharmaceuticals Closes Third Tranche of US$20 Million Convertible Note Financing
PremiumCompany Announcements
CASI Pharmaceuticals Closes Third Tranche of US$20 Million Convertible Note Financing
4M ago
6K
CASI
CASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure
PremiumCompany AnnouncementsCASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure
4M ago
6K
CASI
CASI Pharmaceuticals Secures China Drug Registration for Thiotepa Ahead of Planned Asset Disposal
Premium
Company Announcements
CASI Pharmaceuticals Secures China Drug Registration for Thiotepa Ahead of Planned Asset Disposal
4M ago
6K
CASI
CASI Pharmaceuticals Fails to Renew FOLOTYN Import License in China, Halts Sales
Premium
Company Announcements
CASI Pharmaceuticals Fails to Renew FOLOTYN Import License in China, Halts Sales
5M ago
6K
CASI
Casi Pharmaceuticals announces NMPA approval of CTA for Phase 1/2 CID-103 study
PremiumThe Fly
Casi Pharmaceuticals announces NMPA approval of CTA for Phase 1/2 CID-103 study
5M ago
CASI
CASI Pharmaceuticals Closes Second Tranche of US$20 Million Convertible Note Financing
PremiumCompany Announcements
CASI Pharmaceuticals Closes Second Tranche of US$20 Million Convertible Note Financing
5M ago
6K
CASI
Casi Pharmaceuticals announces results from Phase 1 study of CID-103
PremiumThe Fly
Casi Pharmaceuticals announces results from Phase 1 study of CID-103
5M ago
CASI
CASI Pharmaceuticals Closes First US$5 Million Tranche of Convertible Note Financing
PremiumCompany Announcements
CASI Pharmaceuticals Closes First US$5 Million Tranche of Convertible Note Financing
6M ago
6K
CASI
CASI Pharmaceuticals Wins Nasdaq Listing Extension to February 2026
PremiumCompany AnnouncementsCASI Pharmaceuticals Wins Nasdaq Listing Extension to February 2026
6M ago
6K
CASI
CASI Pharmaceuticals Secures $20 Million for Renal AMR Study
Premium
Company Announcements
CASI Pharmaceuticals Secures $20 Million for Renal AMR Study
6M ago
6K
CASI
Casi Pharmaceuticals enters into $20M convertible note financing
Premium
The Fly
Casi Pharmaceuticals enters into $20M convertible note financing
6M ago
CASI
Buy Rating for CASI Pharmaceuticals: Promising CID-103 Clinical Data and Competitive Positioning
PremiumRatings
Buy Rating for CASI Pharmaceuticals: Promising CID-103 Clinical Data and Competitive Positioning
6M ago
CASI
Casi Pharmaceuticals announces CID-103 immune thrombocytopenia study results
PremiumThe Fly
Casi Pharmaceuticals announces CID-103 immune thrombocytopenia study results
6M ago
CASI
CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman
PremiumCompany Announcements
CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman
7M ago
6K
CASI
Casi Pharmaceuticals appoints James Huang as non-executive chairman
PremiumThe Fly
Casi Pharmaceuticals appoints James Huang as non-executive chairman
7M ago
CASI
CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal
PremiumCompany AnnouncementsCASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal
7M ago
6K
CASI
CASI Pharmaceuticals Appeals Nasdaq Delisting Determination
Premium
Company Announcements
CASI Pharmaceuticals Appeals Nasdaq Delisting Determination
7M ago
6K
CASI
CASI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CASI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
CASI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >